chr11-47337454-AGACGC-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000256.3(MYBPC3):βc.2534_2538delβ(p.Arg845LeufsTer37) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,120 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. R845R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000256.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.2534_2538del | p.Arg845LeufsTer37 | frameshift_variant | 25/35 | ENST00000545968.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2534_2538del | p.Arg845LeufsTer37 | frameshift_variant | 25/35 | 5 | NM_000256.3 | P4 | |
MYBPC3 | ENST00000399249.6 | c.2534_2538del | p.Arg845LeufsTer37 | frameshift_variant | 24/34 | 5 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.*39_*43del | 3_prime_UTR_variant, NMD_transcript_variant | 25/27 | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461120Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 726830
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 10, 2012 | A deletion of 5 nucleotides in exon 25 of the MYBPC3 gene. The normal sequence with the bases that are deleted in braces is: ATGC{GCGTC}TACG. This mutation is denoted c.2534_2538delGCGTC at the cDNA level or at the protein level as p.Arg845LeufsX37. The c.2534_2538delGCGTC mutation in the MYBPC3 gene has been reported previously in one individual with HCM and it was not present in 200 control chromosomes (Richard P, 2003). The c.2534_2538delGCGTC mutation causes a shift in reading frame starting at codon Arginine 845, changing it to a Leucine, and creates a premature stop codon at position 37 of the new reading frame. This mutation is expected to result in an abnormal, truncated protein or in absence of protein from this allele due to mRNA decay. The variant is found in HCM panel(s). - |
Pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Mar 11, 2022 | - - |
Hypertrophic cardiomyopathy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 21, 2011 | The Arg845fs variant has been reported in the literature in 1 family with HCM, w as absent from 400 control chromosomes, and segregated with disease in 5 affecte d family members (Carrier 1997, Richard 2003). In addition, this variant is pre dicted to cause a frameshift, which alters the protein's amino acid sequence beg inning at codon 845 and leads to a premature stop codon 37 amino acids downstrea m. This alteration is then predicted to lead to a truncated or absent protein. Loss of function is an established mechanism of disease for the MYBPC3 gene. Th erefore, the Arg845fs variant meets our criteria for pathogenicity (http://pcpgm .partners.org/lmm) based on segregation, absence in controls, and impact of the variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 06, 2022 | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg845Leufs*37) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This premature translational stop signal has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 9048664, 27532257). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 42635). This variant is also known as c.2566_2570del. - |
Hypertrophic cardiomyopathy 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 1997 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at